q1ymammogramdyslipidemia≥5.7%≥ 126mg/dL40-59 y.o.,ASCVD ≥10%, lowbleeding riskHepatitisB50y.o.aspirininsufficientevidenceforscreening40y.o.community-dwelling,postmenopausalwomencervicalcancerTimedup andgo testq2yq1y≤q2yanxiety40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsq5ybreastcancerq1-2ymammogrambased on lifeexpectancy /health status≥ 140mg/dLpneumococcalHepatitisCmultidoseinitial series,then 1 doseat 2-6months3%40-70 y.o.,ASCVD ≥10%, lowbleeding riskaromataseinhibitorstobaccouseFractureRiskAssessmentTool1 dose; 2doses (2-6monthsapart) ifimmunocomp< 60y.o.75y.o.q15ycardiovasculardisease60y.o.raloxifenecolorectalcancertamoxifenovariancancerstatin≥6.5%diabetes52y.o.≥ 100mg/dLlungcancer≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factordementia2 doses,2-6monthsapartPREVENTequationHIV65y.o.Gailmodel≥ 200mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorTyrer-Cuzickmodelherpeszosteroverweight/ obesitywomenage 55-64 y.o.hormonetherapyhypertension≥20%depressionq3yq1ymammogramdyslipidemia≥5.7%≥ 126mg/dL40-59 y.o.,ASCVD ≥10%, lowbleeding riskHepatitisB50y.o.aspirininsufficientevidenceforscreening40y.o.community-dwelling,postmenopausalwomencervicalcancerTimedup andgo testq2yq1y≤q2yanxiety40-75 y.o., LDL≥ 190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactorsq5ybreastcancerq1-2ymammogrambased on lifeexpectancy /health status≥ 140mg/dLpneumococcalHepatitisCmultidoseinitial series,then 1 doseat 2-6months3%40-70 y.o.,ASCVD ≥10%, lowbleeding riskaromataseinhibitorstobaccouseFractureRiskAssessmentTool1 dose; 2doses (2-6monthsapart) ifimmunocomp< 60y.o.75y.o.q15ycardiovasculardisease60y.o.raloxifenecolorectalcancertamoxifenovariancancerstatin≥6.5%diabetes52y.o.≥ 100mg/dLlungcancer≥ 40 y.o.; LDL ≥190 or DM orASCVD ≥ 20 %or ASCVD ≥5% + riskfactors40-75 y.o.,ASCVD ≥7.5%, ≥ 1risk factordementia2 doses,2-6monthsapartPREVENTequationHIV65y.o.Gailmodel≥ 200mg/dL40-75 y.o.;LDL > 190 orASCVD ≥10% + ≥ 1risk factorTyrer-Cuzickmodelherpeszosteroverweight/ obesitywomenage 55-64 y.o.hormonetherapyhypertension≥20%depressionq3y

Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
  1. q1y mammogram
  2. dyslipidemia
  3. ≥ 5.7%
  4. ≥ 126 mg/dL
  5. 40-59 y.o., ASCVD ≥ 10%, low bleeding risk
  6. Hepatitis B
  7. 50 y.o.
  8. aspirin
  9. insufficient evidence for screening
  10. 40 y.o.
  11. community-dwelling, postmenopausal women
  12. cervical cancer
  13. Timed up and go test
  14. q2y
  15. q1y
  16. ≤ q2y
  17. anxiety
  18. 40-75 y.o., LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  19. q5y
  20. breast cancer
  21. q1-2y mammogram based on life expectancy / health status
  22. ≥ 140 mg/dL
  23. pneumococcal
  24. Hepatitis C
  25. multidose initial series, then 1 dose at 2-6 months
  26. 3%
  27. 40-70 y.o., ASCVD ≥ 10%, low bleeding risk
  28. aromatase inhibitors
  29. tobacco use
  30. Fracture Risk Assessment Tool
  31. 1 dose; 2 doses (2-6 months apart) if immunocomp
  32. < 60 y.o.
  33. 75 y.o.
  34. q15y
  35. cardiovascular disease
  36. 60 y.o.
  37. raloxifene
  38. colorectal cancer
  39. tamoxifen
  40. ovarian cancer
  41. statin
  42. ≥ 6.5%
  43. diabetes
  44. 52 y.o.
  45. ≥ 100 mg/dL
  46. lung cancer
  47. ≥ 40 y.o.; LDL ≥ 190 or DM or ASCVD ≥ 20 % or ASCVD ≥ 5% + risk factors
  48. 40-75 y.o., ASCVD ≥ 7.5%, ≥ 1 risk factor
  49. dementia
  50. 2 doses, 2-6 months apart
  51. PREVENT equation
  52. HIV
  53. 65 y.o.
  54. Gail model
  55. ≥ 200 mg/dL
  56. 40-75 y.o.; LDL > 190 or ASCVD ≥ 10% + ≥ 1 risk factor
  57. Tyrer-Cuzick model
  58. herpes zoster
  59. overweight / obesity
  60. women age 55-64 y.o.
  61. hormone therapy
  62. hypertension
  63. ≥ 20%
  64. depression
  65. q3y